Categories
Investors

CDC Experts Disagree With Pfizer on COVID Boosters, Threatening Pharma Giants Billion Dollar Revenue Stream Children’s Health Defense [Video]

Watch/Read More

The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It's free.

As Pfizer makes plans to keep its billion dollar revenue stream going — by assuring investors yearly COVID booster doses will be needed long after the pandemic ends — a group of scientists from the Centers for Disease Control and Prevention (CDC) said there isn’t enough data to recommend COVID booster shots to the general population.

The COVID-19 working group of the CDC’s Advisory Committee on Immunization Practices (ACIP) said June 23, they would only recommend booster shots if there’s a demonstrated decline in efficacy –– not just a waning antibody response.

Boosters may also be recommended if there’s a variant that’s able to evade the vaccines, according to slides presented by Sara Oliver, M.D., a medical epidemiologist with CDC’s National Center for Immunization and Respiratory Diseases.

Currently, there’s no evidence …